- Home
- MOBX vs ICCM Comparison
MOBX vs ICCM Comparison
Compare MOBX & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MOBX | ICCM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | Israel |
| Employees | 46 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6M | 43.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | MOBX | ICCM |
|---|---|---|
| Price | $0.57 | $0.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | ★ 107.3M | 180.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $31.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.54 |
| 52 Week High | $1.44 | $1.52 |
Technical Indicators
Market Signals| Indicator | MOBX | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 52.36 | 67.83 |
| Support Level | $0.22 | $0.68 |
| Resistance Level | $0.84 | $0.74 |
| Average True Range (ATR) | 0.21 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 34.94 | 91.33 |
Price Performance
Historical ComparisonAbout MOBX Mobix Labs Inc.
Mobix Labs Inc designs, develops and sells components and systems for wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies. Its wireless systems solutions include products for RF and millimeter wave (mmWave) communications, mmWave imaging, software defined radio and custom RF integrated circuits (ICs) targeting the defense, aerospace, commercial and industrial sectors. The majority of the company's revenue is derived from product sales to equipment manufacturers. Geographically, it generates the maximum revenue from the United States.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.